Davis Robert M, EVP, Global Svcs & CFO, subtracted 216,718 shares of Merck & Co., Inc. (MRK) from its portfolio at the rate of $85.43 per share valuing $18,514,032 on Jun 25. The insider left behind 137,660 shares of the company to its portfolio. Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of Merck & Co., Inc. (MRK) was $85.52. Currently, the 1st Resistance Point for this stock is $86.18, with a 2nd Resistance Point sitting at $86.84. Meanwhile, this company’s stock has a 1st Support Level at $84.78 and a 2nd Support Level at $84.05. Merck & Co., Inc. (MRK) stock has gained $1.05, or 1.24%, in the past five days. In the last full month, these shares have gained $0.66, or 0.78%. In the past three months, this stock’s price has risen by $7.19, or 9.18%. This year-to-date, Merck & Co., Inc. (MRK) shares have gained $9.11, or 11.92%.
Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For Merck & Co., Inc. (MRK) stock, 50% of short-term indicators suggest that these shares are a “ Buy .” Meanwhile, 100% of medium-term indicators point to this stock being a “ Buy .”
With 2,574,645 K shares outstanding, this company currently has a market capitalization of $218,149,680K. Merck & Co., Inc. (MRK) generates $42,294 M in annual sales, amounting to annual net income of $6,220 M. This stock has generated a 1-Year Total Return of 29.58%, a 3-Year Total Return of 35.00%, and a 5-year Total Return of 45.91%. This stock’s 5-Year Dividend Growth is 15.03%, with its most recent dividend valued at $0.550 per share on 06/14/19. Its Annual Dividend Yield is 2.57%, and its Annual Dividend Rate is 2.20.
In the most recently-reported fiscal quarter, which ended in Jun-19, Merck & Co., Inc. (MRK) reported earnings of $1.30 per share. Wall Street analysts, on average, were expecting the company to report earnings of $1.16 per share, representing a 0.14 difference and 12.23% surprise. In the previous quarter ending in Mar-19, the reported earnings of $1.22 represented a 0.16 difference from the consensus estimate calling for $1.06 per share, which was a 15.11% surprise.
For the current fiscal quarter, which is set to end in 09/2019, the average earnings estimate is $1.26 per share. This estimate came from a total of 3 Wall Street Analysts. Of those market experts, the high estimate was $1.30 and the low estimate was $1.22. In the year-ago quarter, Merck & Co., Inc. (MRK) generated per-share earnings of $1.19. If the analysts are correct about the current quarter’s earnings, the growth will be +5.88% .
Turning our focus now to insider trading activity, there have been 1 purchases (216,718 shares in total) and 2 sale (216,718 shares in total) in the last 3 months. In the last 6 months, there have been 35 insider buys amounting to 1,307,510 shares and 26 insider sales amounting to 1,099,548 shares. In the past full year, 49 insider purchases were made (involving 2,825,820 shares) and 39 insider sell-offs equivalent to 2,623,270 shares.
Moving onto liquidity, Merck & Co., Inc. (MRK) has a Current Ratio of 1.17, a Quick Ratio of 0.92 and a Cash Ratio of 0.40. Looking at this company’s capital structure, its Total Debt to Total Equity is 94.06, its Total Debt to Total Capital is 48.47, and its Total Debt to Total Assets is now 30.39. Looking even further ahead into the future, its Long-Term Debt to Equity is 74.18 and its Long-Term Debt to Total Capital is 38.22.